- About
- MSOs / Provider Groups
- Healthcare CFOs
- Health Systems
- Life Sciences
- Private Equity
- Lenders
- Capabilities
- About
- MSOs / Provider Groups
- Healthcare CFOs
- Health Systems
- Life Sciences
- Private Equity
- Lenders
- Capabilities
A multi-specialty DSO with approximately 250 clinics across 6 states was experiencing meaningful growth up until H2’22, when hurricane-related site closures, expense management challenges, new provider hire-ramp up, and challenging labor markets led to a high leverage ratio, resulting in a limited availability of capital. Additionally, wide performance dispersions across certain historical acquisitions and regional markets created further downward pressure on margins. The underperforming sites coupled with the DSO’s suboptimal reporting and analytics program led management to engage SCALE to formalize a performance improvement plan for its lenders.
SCALE made near-term, mid-term, and long-term recommendations regarding underperforming sites & performance turnaround, cash flow, financial reporting, and determined cost savings opportunities for HR, IT, and RCM. The final report was presented to the client’s private equity sponsors and ultimately received praise for its exhaustive and targeted findings. The assessment resulted in the successful implementation of the change in control, and SCALE has continued to be involved in a PMO role to supervise the implementation of our recommendations.
Benchmarking data suggests opportunity to improve rates in key markets, implying an 8-15% uplift to EBITDA across the network
Improving productivity of underperforming GP doctors by improving provider retention, enhancing provider onboarding training and development, increasing Saturday scheduling utilization, and developing Dental Assistant capabilities would represent a 7-9% uplift to EBITDA.
Expanding specialty coverage and productivity in underperforming regions would represent a 4-8% uplift to EBITDA
Improving hygiene coverage and productivity in underperforming sites to get to benchmark represents a 2-3% EBITDA opportunity
Completing 1 to 3 acquisitions in existing markets with strong operational leadership can increase EBITDA by 5-14%
Potential PSC headcount reductions based on 3 year forecast model can increase EBITDA 5-6%
Strategically pursue expansion opportunities to realize an incremental 3-6% uplift in EBITDA
Strategically increase Medicaid coverage in underutilized sites, representing a 1-2% EBITDA uplift opportunity
SCALE Healthcare is based on the foundation of a singular focus – elevating management performance across healthcare services. We are focused on the entire suite of operational advisory and diligence services exclusively to healthcare service organizations, with local team presence across 10 states.
Unlike the many consulting firms that offer more narrow and often more impractical solutions borne of limited or very general expertise, we rely on our team of 75+ carefully selected senior operational healthcare experts to ensure we provide the most relevant and value added experience across the full range of management disciplines and clinical specialties that fall within healthcare services.
Be a leading voice in the healthcare services industry.
Please fill out the form below to sign up for the SCALE newsletter.
Please fill out the details below and a team member will reach out to you.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.